Abstract

The progression of human degenerative and hypoxic/ischemic diseases is accompanied by widespread cell death. One death process linking iron-catalyzed reactive species with lipid peroxidation is ferroptosis, which shows hallmarks of both programmed and necrotic death in vitro. While evidence of ferroptosis in neurodegenerative disease is indicated by iron accumulation and involvement of lipids, a stable marker for ferroptosis has not been identified. Its prevalence is thus undetermined in human pathophysiology, impeding recognition of disease areas and clinical investigations with candidate drugs. Here, we identified ferroptosis marker antigens by analyzing surface protein dynamics and discovered a single protein, Fatty Acid-Binding Protein 5 (FABP5), which was stabilized at the cell surface and specifically elevated in ferroptotic cell death. Ectopic expression and lipidomics assays demonstrated that FABP5 drives redistribution of redox-sensitive lipids and ferroptosis sensitivity in a positive-feedback loop, indicating a role as a functional biomarker. Notably, immunodetection of FABP5 in mouse stroke penumbra and in hypoxic postmortem patients was distinctly associated with hypoxically damaged neurons. Retrospective cell death characterized here by the novel ferroptosis biomarker FABP5 thus provides first evidence for a long-hypothesized intrinsic ferroptosis in hypoxia and inaugurates a means for pathological detection of ferroptosis in tissue.

Details

Title
Fatty acid-binding protein 5 is a functional biomarker and indicator of ferroptosis in cerebral hypoxia
Author
Peng, Hao 1 ; Xin, Shan 2   VIAFID ORCID Logo  ; Pfeiffer, Susanne 1 ; Müller, Constanze 3 ; Merl-Pham, Juliane 4 ; Hauck, Stefanie M. 4 ; Harter, Patrick N. 5 ; Spitzer, Daniel 6 ; Devraj, Kavi 7 ; Varynskyi, Borys 8 ; Arzberger, Thomas 9 ; Momma, Stefan 6   VIAFID ORCID Logo  ; Schick, Joel A. 1   VIAFID ORCID Logo 

 Helmholtz Zentrum Munich, Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Helmholtz Zentrum Munich, Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Yale University School of Medicine, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710) 
 Helmholtz Zentrum Munich, Research Unit Analytical BioGeoChemistry, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Helmholtz Zentrum Munich, Metabolomics and Proteomics Core, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Center for Neuropathology and Prion Research, Munich, Germany (GRID:grid.4567.0) 
 Goethe University, Institute of Neurology (Edinger Institute), Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721) 
 Goethe University, Institute of Neurology (Edinger Institute), Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Birla Institute of Science and Technology Pilani, Department of Biological Sciences, Hyderabad, India (GRID:grid.418391.6) (ISNI:0000 0001 1015 3164) 
 Helmholtz Zentrum Munich, Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Zaporizhzhia State Medical and Pharmaceutical University, Physical and Colloidal Chemistry Department, Pharmaceutical Faculty, Zaporizhzhia, Ukraine (GRID:grid.4567.0) 
 Center for Neuropathology and Prion Research, Munich, Germany (GRID:grid.4567.0); Ludwig-Maximilians-University Munich, Department of Psychiatry and Psychotherapy, University Hospital, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X) 
Pages
286
Publication year
2024
Publication date
Apr 2024
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3048575768
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.